Hamill John P.

Average Profitability
<0.0001%
Insider Buys Quantity
4
Insider Buys Sum
$17,360.59
Insider Sells Quantity
0
Insider Sells Sum
$0

Insider Activity of Hamill John P.

According to the SEC Form 4 filings, Hamill John P., being in a position of

  1. SrVP/CFO/Prin Fin & Acct Ofcr at Aprea Therapeutics, Inc.,
    оver the last 12 months, has bought 1510 shares for $8,661, and sold 0 shares,
    over all time since 2024-03-13, has bought 1510 shares for $8,661, and sold 0 shares.

The largest purchase of all time was on 2019-05-31 and amounted to 15000 shares of Trevena, Inc. for $8,700.

Biography of Hamill John P.

No biography is available at this moment.

2024-10-11PurchaseAprea Therapeutics, Inc.
APRE
SrVP/CFO/Prin Fin & Acct Ofcr
50
0.0008%
$2.46$123+52.69%
2024-10-10PurchaseAprea Therapeutics, Inc.
APRE
SrVP/CFO/Prin Fin & Acct Ofcr
450
0.0074%
$2.61$1,175+55.31%
2024-03-13PurchaseAprea Therapeutics, Inc.
APRE
SrVP/CFO/Prin Fin & Acct Ofcr
1,010
0.0345%
$7.29$7,363-22.97%
2019-05-31PurchaseTrevena, Inc.
TRVN
VP Fin,Princ Fin&Acct Officer
15,000
0.0081%
$0.58$8,700-23.91%
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.